SciClone Pharmaceuticals, Inc. (SCLN) 是一家上市公司 属于 医疗保健 板块,经营于 制药 - 专科与仿制药 行业.
SCLN 拥有 IPO日期为 1992-03-17, 在 NASDAQ.
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.